What to do in case of post intravitreal injection bleeding?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Post-Intravitreal Injection Bleeding

In case of post-intravitreal injection bleeding, observation and conservative management is the recommended approach as most cases resolve spontaneously without intervention.

Types of Post-Injection Bleeding

Subconjunctival Hemorrhage

  • Most common and benign form of bleeding
  • Appears as bright red patch on the white of the eye
  • Typically resolves spontaneously within 1-2 weeks
  • No specific treatment required beyond reassurance 1

Anterior Chamber Bleeding

  • Less common complication
  • Can occur without associated vitreous hemorrhage
  • Conservative management is appropriate in most cases 2
  • Monitor intraocular pressure to ensure no complications develop

Vitreous Hemorrhage

  • More serious but less common complication
  • May temporarily obscure vision
  • Requires careful monitoring but often resolves without intervention
  • Position patient with head elevated to help blood settle 1

Management Protocol

Immediate Assessment

  1. Evaluate visual acuity to establish baseline
  2. Measure intraocular pressure to rule out pressure-related complications
  3. Perform slit-lamp examination to determine location and extent of bleeding
  4. Conduct fundus examination (if possible) to assess retinal status

Management Steps

  1. For minor bleeding (subconjunctival hemorrhage):

    • Reassure patient about benign nature
    • No intervention required
    • Follow-up as scheduled for the underlying condition
  2. For anterior chamber bleeding:

    • Conservative management is typically sufficient 2
    • Monitor intraocular pressure
    • Consider topical anti-inflammatory drops if significant inflammation present
  3. For vitreous hemorrhage:

    • Head elevation to allow blood to settle
    • More frequent follow-up (1-2 weeks initially) 1
    • B-scan ultrasonography if fundus cannot be visualized to rule out retinal detachment

Warning Signs Requiring Urgent Attention

  • Sudden worsening of pain or vision
  • Significant increase in intraocular pressure
  • Signs of infection (increasing redness, pain, photophobia)
  • Persistent or worsening hemorrhage

Prevention of Bleeding Complications

  • Proper injection technique with needle directed toward optic nerve via pars plana
  • Use of povidone-iodine prior to injection
  • Adequate anesthesia to prevent sudden movement
  • Applying gentle pressure at injection site after needle withdrawal 1
  • Consider topical naphazoline to reduce conjunctival hemorrhage 3

Special Considerations

  • In patients on anticoagulants, continuation of therapy is generally recommended as the risk of thromboembolic events outweighs the risk of serious hemorrhagic complications 1
  • For diabetic patients receiving anti-VEGF injections, regular follow-up is essential as they may be at higher risk for complications 1

Follow-up Schedule

  • For minor bleeding: routine follow-up for underlying condition
  • For moderate bleeding: 1-week follow-up
  • For significant bleeding: 2-3 day follow-up with consideration of more frequent monitoring

Most post-intravitreal injection bleeding is self-limiting and resolves without intervention. The primary focus should be on monitoring for potential complications while providing appropriate reassurance to the patient.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Ocular pain after intravitreal injection.

Current eye research, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.